Company intelligence / Profile preview

ODC Life Sciences

Boituva, Sao Paulo, Brazillinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

ODC Life Sciences is an active Brazilian-based healthcare services company specializing in connecting patients in Latin America with novel therapies and clinical trials. It provides comprehensive support for biotech companies seeking to conduct clinical research or commercialize orphan drugs in the region. Its impact includes over 500 rare disease patients randomized into studies, with rapid regulatory approval timelines for trial protocols and drug dossiers[2].

Therapeutic areas: Rare Diseases
Modalities: Small moleculeGene therapy
Industry: Contract Research Organization

Beyond the preview

Go deeper on ODC Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ODC Life Sciences.

Explore the full profile